Cancer Vaccine Collaborative

You won't know how to vaccinate until you know how to immunize.
And you won't know how to immunize until you know how to monitor.

Lloyd J. Old, M.D.
Director, Cancer Vaccine Collaborative

About LICR

The Ludwig Institute for Cancer Research engages leading scientists and clinicians from around the world in an integrated effort to understand and control the global problem of cancer. LICR is convinced that early-phase clinical investigations are the last step of the initial discovery phase and not the first step of a new drug development phase. Thus, in addition to an abiding commitment to fundamental laboratory investigation, LICR takes responsibility for identifying and assessing the therapeutic utility of discoveries made in its laboratories by sponsoring and conducting clinical trials.

About CRI

The Cancer Research Institute was founded in 1953 to foster research that will yield an understanding of the immune system and its response to cancer, with the ultimate goal of developing immunological methods for the treatment and prevention of the disease. To accomplish these goals, CRI supports scientists at all stages of their careers and funds every step of the research process, from basic laboratory studies to clinical trials testing novel immunotherapies. Guided by a Scientific Advisory Council, which includes four Nobel Prize winners and 24 members of the National Academy of Sciences, CRI awards fellowships and grants to scientists around the world. The Institute’s scientific strength and excellence are matched by its fiscal integrity with 90 cents of every dollar raised used to directly support its research and medically related programs.

Lloyd J. Old, M.D.
Director, Ludwig Institute for Cancer Research and
Director, Cancer Vaccine Collaborative

Jill O’Donnell-Tormey, Ph.D.,
Executive Director, Cancer Research Institute

For more information, please contact:

Ludwig Institute for Cancer Research
Office of Communications
communications@licr.org
www.licr.org